Expanding Opportunities for Living Donation: Recommendations From the 2023 Santander Summit to Ensure Donor Protections, Informed Decision Making, and Equitable Access
Krista L. Lentine(Saint Louis University Hospital), David Thomson(The Christie NHS Foundation Trust), Michael Spiro(The London College), Martín Torres, Beatriz Domínguez‐Gil(Universidad de Zaragoza), Christopher J.E. Watson(Cambridge University Hospitals NHS Foundation Trust), Matthew Cooper(Medical College of Wisconsin), Amy D. Waterman(Houston Methodist), Mohamed Rela(Bharath University), Kristof Van Assche(University of Antwerp), Dale Gardiner(NHS Blood and Transplant), Gabriel M. Danovitch(University of California, Los Angeles), Sanjay Nagral(Jaslok Hospital), Francis L. Delmonico(Massachusetts Medical Society)
Cited by 26
Related Papers
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
|Circulation|2019|1.3k
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716
Kidney Transplantation as Primary Therapy for End-Stage Renal Disease
|Clinical Journal of the American Society of Nephrology|2008|623
Use of Monoclonal Antibodies to T-Cell Subsets for Immunologic Monitoring and Treatment in Recipients of Renal Allografts
|New England Journal of Medicine|1981|513
Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit
|American Journal of Transplantation|2010|505